← All medicines
Prevenar 13 suspension for injection pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)
Licence EU/1/09/590/1-6 · Unknown
- Licence holder
- Pfizer Europe MA EEIG (all products →)
- Active substances
- Polysaccharide serotype 14, Polysaccharide serotype 23f, Polysaccharide serotype 19f, Polysaccharide serotype 9v, Polysaccharide serotype 3, Polysaccharide serotype 1, Polysaccharide serotype 6a, Polysaccharide serotype 7f, Polysaccharide serotype 4, Polysaccharide serotype 6b, Oligosaccharide serotype 18c, Polysaccharide serotype 5, Polysaccharide serotype 19a
- Dosage form
- Suspension for injection
- Route of administration
- Intramuscular use
- ATC codes
- J07AL, J07AL02
- First authorised
- 09/12/2009
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.